Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
-.--%-.--%-8.89x4.14x3.94x-7.28x-6.83x 2.21B
0.59%0.68%17.24x1.95x3.69x9.5x11.02x 66.32B
0.6%0.62%26.03x3.94x5.39x15.83x19.62x 52.6B
-.--%-.--%33.71x6.94x11.47x21.71x25.74x 43.27B
3.53%3.62%-42.82x2.4x3.08x9.11x10.63x 38.64B
-.--%-.--%24.39x1.59x3.47x11.8x13.68x 29.62B
-.--%-.--%56.3x4.18x3.29x27.65x28.03x 23.31B
-.--%-.--%-6.59x3.99x9.17x-5.65x-5.29x 22.62B
-.--%0.05%65.79x5.91x6.47x44.55x50.25x 20.22B
-.--%-.--%24.1x3.53x5.16x13.51x18.67x 16.29B
-.--%-.--%-37.28x-6.61x17.78x-48.68x-56.26x 16.26B
-.--%-.--%-117.16x12792.9x12.58x-90.09x-125.57x 12.43B
-.--%-.--%17.43x - 3.59x13.87x16.19x 11.38B
-.--%-.--%43.85x - - - - 9.65B
0.17%0.17%56.08x22.87x33.96x48.03x49.53x 11.13B
2.76%3.15%12.47x1.11x1.83x7.37x9.96x 6.46B
Average 0.48% 0.52% 10.29x 917.77x 8.32x 4.75x 3.96x 23.9B
Weighted average by Cap. 0.59% 0.63% 13.52x 443.59x 7.05x 9.53x 10.34x
Biopharmaceuticals